2011
DOI: 10.1308/147870811x589588
|View full text |Cite
|
Sign up to set email alerts
|

Functional colonic obstruction in an adult as a presenting feature of thymoma

Abstract: Functional colonic obstruction is a colonic motility disorder with a number of causes. One cause is myenteric ganglionitis, which may result from paraneoplastic processes. We present the case of a previously healthy 53-year-old man who presented with a week's history of functional colonic obstruction. A transverse loop colostomy failed to resolve his symptoms and he subsequently underwent an extended right hemicolectomy. Histology demonstrated lymphocytic myenteric ganglionitis that was felt to be of paraneopl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 3 publications
0
2
0
Order By: Relevance
“…Malhotra et al successfully treated a patient with thymoma and AP-CIPO with an extended right hemicolectomy when the patient failed to respond to transverse loop colostomy. 11 Our patient was treated with methylprednisolone, pyridostigmine, and a thymectomy, which led to symptom resolution. This approach has been recommended for thymoma-related AP-CIPO because it shares myasthenic features for which combination therapy improves symptoms at the neuromuscular junction and, thus, the gastrointestinal motility.…”
Section: Discussionmentioning
confidence: 86%
“…Malhotra et al successfully treated a patient with thymoma and AP-CIPO with an extended right hemicolectomy when the patient failed to respond to transverse loop colostomy. 11 Our patient was treated with methylprednisolone, pyridostigmine, and a thymectomy, which led to symptom resolution. This approach has been recommended for thymoma-related AP-CIPO because it shares myasthenic features for which combination therapy improves symptoms at the neuromuscular junction and, thus, the gastrointestinal motility.…”
Section: Discussionmentioning
confidence: 86%
“…Autoantibodypatterns include VGKC as well as neuronal AChR as targets. Prokinetic agents (i.e., pyridostigmine) and immunosuppressive therapies (corticosteroids, intravenous immunoglobulins) were utilized (85)(86)(87)(88)(89).…”
Section: Chronic Gastrointestinal Dysmotility/pseudoobstructionmentioning
confidence: 99%